Loading...
Bausch Health Companies Inc.
BHC.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$8.83
CA$0.09(1.03%)
Bausch Health Companies Inc. (BHC.TO) Financial Performance & Statements
Review Bausch Health Companies Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.69%
↑ 8.69%
Operating Income Growth
60.54%
↑ 60.54%
Net Income Growth
92.23%
↑ 92.23%
Operating Cash Flow Growth
54.75%
↑ 54.75%
Operating Margin
15.84%
↑ 15.84%
Gross Margin
70.78%
↑ 70.78%
Net Profit Margin
-0.41%
↓ 0.41%
ROE
3.33%
↑ 3.33%
ROIC
6.95%
↑ 6.95%
Bausch Health Companies Inc. (BHC.TO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Bausch Health Companies Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.56B | $2.51B | $2.40B | $2.14B |
| Cost of Revenue | $727.00M | $977.80M | $988.80M | $909.92M |
| Gross Profit | $1.83B | $1.53B | $1.41B | $1.23B |
| Gross Profit Ratio | $0.72 | $0.61 | $0.59 | $0.58 |
| R&D Expenses | $145.00M | $161.00M | $155.97M | $150.33M |
| SG&A Expenses | $820.00M | $850.00M | $831.83M | $790.45M |
| Operating Expenses | $1.27B | $996.00M | $987.80M | $940.78M |
| Total Costs & Expenses | $2.001B | $1.98B | $1.98B | $1.85B |
| Interest Income | $9.00M | $7.00M | $8.00M | $9.00M |
| Interest Expense | $337.00M | $346.00M | $350.00M | $355.00M |
| Depreciation & Amortization | $307.00M | $324.59M | $317.93M | $318.57M |
| EBITDA | $853.00M | $647.00M | $718.85M | $606.28M |
| EBITDA Ratio | $0.33 | $0.26 | $0.30 | $0.28 |
| Operating Income | $558.00M | $318.00M | $425.91M | $292.69M |
| Operating Income Ratio | $0.22 | $0.13 | $0.18 | $0.14 |
| Other Income/Expenses (Net) | -$349.00M | -$339.00M | -$341.00M | -$350.00M |
| Income Before Tax | $209.00M | -$21.00M | $47.99M | -$68.69M |
| Income Before Tax Ratio | $0.08 | -$0.008 | $0.02 | -$0.03 |
| Income Tax Expense | $111.00M | $71.57M | $48.99M | $7.96M |
| Net Income | $93.00M | -$85.00M | $10.00M | -$63.71M |
| Net Income Ratio | $0.04 | -$0.03 | $0.004 | -$0.03 |
| EPS | $0.25 | -$0.23 | $0.03 | -$0.17 |
| Diluted EPS | $0.25 | -$0.23 | $0.03 | -$0.17 |
| Weighted Avg Shares Outstanding | $368.00M | $368.40M | $367.90M | $366.80M |
| Weighted Avg Shares Outstanding (Diluted) | $368.00M | $368.40M | $370.20M | $366.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan